#
##
##
##
|||Pages|
|---|---|---|
|Trustees'
annual
report||1to 5|
|Independent
examiner's
report to the trustees|||
|Statement offinancial|activities||
|Statement offinancial|position||
|Notes to the financial statements||9to 14|
##
##
|Reference and administrative|Reference and administrative|Reference and administrative|details|||
|---|---|---|---|---|---|
|Registered|charity|name|Sheffield Area Kidney Association|||
|Charity registration||number|1196513|||
|Principal office|||7Talbot Place|||
||||Sheffield|||
||||S22SS|||
|The trustees||||||
||||Mr R Bright|||
||||Mrs SJ Burt|||
||||Mr D W Marshall|||
||||Mr PJ Beattie|||
||||Mr P Joynson|||
||||Mrs G Beattie|||
||||Mrs K Radford|||
||||Mrs CJThompson|||
||||Mr A Raftery|||
|Independent|examiner||Richard
Murdoch||FCA|
||||2Westbrook|Court||
||||Sharrow Vale|Road||
||||Sheffield|||
||||S11BYZ|||
##
##
##
##
##
##
##
##
##
##
##
##
##
#
#
#
##
##
##
##
##
#
#
##
##
##
##
##
##
##
##
||Y|ear|en|ded 31 May|2023|||
|---|---|---|---|---|---|---|---|
||||||2023||2022|
|||||Unrestricted|Restricted|||
|||||funds|funds|Total funds|Total funds|
|||Note||6|6|6|6|
|Income and endowments||||||||
|Donations
and legacies|||4|7,362||7,362|175,558|
|Charitable
activities|||5||||1,325|
|Fundraising
activities|||6|50||50|202|
|Investment
income|||7|36,609||36,609|30,917|
|Total income||||44,021||44,021|208,002|
|Expenditure||||||||
|Expenditure
on raising funds:||||||||
|Charitable
activities|||8|(46,297)||(46,297)|(30,760)|
|Other expenditure|||9|(249)||(249)|(474)|
|Total expenditure||||(46,546)||(46,546)|(31,234)|
|Net losses on investments||'|10|(97,171)||(97,171)|(80,527)|
|Net (expenditure)/income|and net|||||||
|movement
in funds||||(99,696)||(99,696)|96,241|
|Reconciliation
offunds||||||||
|Total funds brought forward||||1,410,554|12,000|1,422,554|1,326,313|
|Total funds carried forward||||1,310,858|12,000|1,322,858|1,422,554|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|4.|Donations||and legacie|s|||||
|---|---|---|---|---|---|---|---|---|
||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
||Donations||||Funds
f|2023
Z|Funds
F|2022
6|
||Donations||||7,362|7,362|25,558|25,558|
||Legacies||||||||
||Legacy Bequests||||||150,000|150,000|
||||||7,362|7,362|175,558|175,558|
|5.|Charitable||activities||||||
||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
||Income from Transplant|||Games|Funds
f|2023
6|Funds
f
1,325|2022
1,325|
|6.|Fundraising||activities||||||
||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
||||||Funds|2023|Funds|2022|
||Christmas|Card Sales|||50|6
50|E
202|E
202|
|7.|Investment||income||||||
||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
||||||Funds|2023|Funds|2022|
||Income from listed investments
Bank Interest Received||||E
34,996
1,613|34,996
1,613|6
30,866
51|30,866
51|
||||||36,609|36,609|30,917|30,917|
##
##
##
##
|8.|Charitable|a|ctivities||||||||
|---|---|---|---|---|---|---|---|---|---|---|
||||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
||||||||Funds
f|2023
E|Funds
F|2022
f|
||Social Work||Fund||||300|300|291|291|
||Patient Aid||||||2,386|2,386|3,835|3,835|
||Hospital Projects||||||21,000|21,000|7,140|7,140|
||Insurance||||||198|198|325|325|
||Transplant|Games Costs|||||5,930|5,930|||
||Bank Charges||||||128|128|177|177|
||Printing
and postage||||||g||53|53|
||Independent||Examiners Fee||||1,950|1,950|1,800|1,800|
||Benefits adviser consultancy||||fees||8,000|8,000|8,000|8,000|
||Legal fees||||||6,396|6,396|9,139|9,139|
||||||||46,297|46,297|30,760|30,760|
|9.|Other expenditure||||||||||
||||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
||||||||Funds|2023|Funds|2022|
||||||||E|E|5||
||Christmas|Cards|||||123|123|185|185|
||Miscellaneous||Expenses||||126|126|289|289|
||||||||249|249|474|474|
|10.|Net losses|on investments|||||||||
||||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
||||||||Funds
f|2023
k|Funds
f|2022
E|
||Gains/(losses)||on listed investments||||(97,171)|(97,171)|(80,527)|(80,527)|
|11.|Independent||examination||fees||||||
||||||||||2023|2022|
||||||||||F|E|
||Fees payable||to the independent|||examiner for:|||||
||Independent||examination|of|the financial||statements||1,800|1,800|
##
##
##
##
##
|||||2023|2022|
|---|---|---|---|---|---|
|||||F.|F|
|Accruals|and|deferred|income|3,133|6,551|
##
|Analysis ofc|haritable|funds|||||
|---|---|---|---|---|---|---|
|Unrestricted|funds||||||
|||At|||Gains and|At|
|||1 June 2022
F|Income
E|Expenditure
E|losses
f|31 Ilay 2023
F|
|General funds||1,410,554|44,021|(46,546)|(97,171)|1,310,858|
|||At|||Gains and|At|
|||1 June 2021|Income
f|Expenditure
F|losses
F|31 May 2022|
|General funds||1,314,313|208,002|(31,234)|(80,527)|1,410,554|
|Restricted funds|||||||
|||At|||Gains and|At|
|||1 June 2022
f|Income
f|Expenditure|losses
F.|31 May 2023
f|
|Operating
Costs
Reserve Fund||12,000||||12,000|
|||At|||Gains and|At|
|||1 June 2021
F|Income
E|Expenditure|fosses
F|31 May 2022
f|
|Operating
Costs
Reserve Fund||12,000||||12,000|
##
##
|Analysi|s ofnet assets between f|unds|||
|---|---|---|---|---|
|||Unrestricted|Restricted|Total Funds|
|||Funds
f|Funds
f|2023|
|Current|assets|1,310,858|12,000|1,322,858|
|||Unrestricted|Restricted|Total Funds|
|||Funds|Funds|2022|
|Current|assets|1,410,554|12,000|1,422,554|
##